openPR Logo
Press release

Bacterial Conjunctivitis Drugs Market is set to garner staggering revenues by 2024

03-06-2018 04:02 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Bacterial Conjunctivitis Drugs Market is set to garner

The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as AzaSite, Zymaxid, Moxeza, and Vigamox, are set to lose their marketing exclusivity very soon.

Get Sample of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12323

The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.

Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth

Apart from this, the rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.

Although the market is facing a number of restraints at present, it may experience a little relief in future if the product development partnerships (PDPs) models for business are implemented by participants. As various research and development procedures incur a high amount, exerting substantial pressure on pharma companies, strategic alliances with small biotech research organizations will prove to be beneficial for both the parties.

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12323

Market Encroachment by Generic Variations to Limit Demand for Topical Fluoroquinolones

Fluoroquinolones, macrolides, and aminoglycosides are the major classes of drugs used for the treatment of bacterial conjunctivitis. The demand for topical fluoroquinolones is the highest among all classes of bacterial conjunctivitis drugs in the U.S. However, the segment is projected to be hindered severely in the coming years, owing to the forthcoming patent expirations of bestselling drugs of this class, such as Vigamox, Moxeza, and Zymaxid by the end of 2016.

The market’s opportunity will also be hurt significantly over the next few years due to the encroachment by generic variations of these drugs and decline from US$361.9 mn in 2013 to US$286.4 mn by 2024.

Enquiry for discount on this report – https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12323

Imminent Patent Expiries to Hurt Leading Players Severely

Valeant Pharmaceuticals Int. Inc., Santen Pharmaceutical Co. Ltd., Pfizer Inc., Perrigo Com. Plc., Novartis AG, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Akorn Inc., and Actavis Plc. are leading the market for bacterial conjunctivitis drugs in the U.S. The imminent patent expiries is likely to hurt the business of these players significantly in the near future. However, the rising prevalence of bacterial infection in eyes and the increasing susceptibility to infection among individuals of various age groups may provide rewarding opportunities to participants over the next few years.

Players are recommended to focus on developing herbal medicines for the treatment of bacterial conjunctivitis, as the consumer preference is shifting from pharmacological medicines to herbal treatment regimens.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drugs Market is set to garner staggering revenues by 2024 here

News-ID: 966983 • Views: 340

More Releases from Transparency Market Research

Hydrogen Peroxide Market to Register a Healthy CAGR of 5.8% for the Forecast Per …
Hydrogen Peroxide Market: Introduction Transparency Market Research delivers key insights on the global hydrogen peroxide market. In terms of revenue, the global hydrogen peroxide market is estimated to expand at a CAGR of 5.8% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecast in its report on the global hydrogen peroxide market. Read report Overview: https://www.transparencymarketresearch.com/hydrogen-peroxide-market.html The global hydrogen peroxide market is broadly affected by several factors
Polyethylene Wax Market to Register a Healthy CAGR of 5.1% for the Forecast Peri …
Polyethylene Wax Market: Introduction Transparency Market Research delivers key insights on the global polyethylene wax market. In terms of revenue, the global polyethylene wax market is estimated to expand at a CAGR of 5.1% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global polyethylene wax market. Read report Overview: https://www.transparencymarketresearch.com/polyethylene-wax-market.html The global polyethylene wax market is broadly affected by several
Specialty Yeast Market Worldwide With Impressive Sales Trends By 2027
Global Specialty Yeast Market: Overview The demand within the global specialty yeast market is rising on account of advancements in the domain of food processing. Several types of snacks and sauces can be manufactured with the help of specialty yeast, and this is a key consideration from the perspective of market growth. The food and beverages industry is characterised by a robust supply chain, and hence, quick acquisition of specialty foods
IV Bottles Market Applications and Regional Insights during the Forecasted Perio …
According to Transparency Market Research's latest report on the global IV bottles market for the forecast period of 2021-2031, the market is projected to be driven by continuous research & development activities in the pharmaceutical packaging, which are leading to developments in the IV bottles in terms of improving barrier properties, and growing demand for recyclable and sustainable packaging for the product The global IV bottles market is expected to expand

All 5 Releases